Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization
Condition: Chronic Limb IschemiaInterventions: Drug: Dexamethasone sodium phosphate injection, USP, 4 mg/mL; Drug: PlaceboSponsor: Mercator MedSystems, Inc.Not yet recruiting - verified June 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials